Iradimed (IRMD) Cash from Operations Growth (3y) (2016 - 2026)
Iradimed (IRMD) Cash from Operations Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 0.50% |
| 10 | Iradimed | 1.24 Bn | 1.18 Bn | 16.81 Mn | 21.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.29% |
| Dec 31, 2025 | 24.91% |
| Sep 30, 2025 | 21.05% |
| Jun 30, 2025 | 67.81% |
| Mar 31, 2025 | 44.38% |
| Dec 31, 2024 | 21.16% |
| Sep 30, 2024 | 39.22% |
| Jun 30, 2024 | 22.96% |
| Mar 31, 2024 | 60.28% |
| Dec 31, 2023 | 16.16% |
| Sep 30, 2023 | 1.44% |
| Jun 30, 2023 | 64.41% |
| Mar 31, 2023 | 57.17% |
| Dec 31, 2022 | -8.36% |
| Sep 30, 2022 | 7.86% |
| Jun 30, 2022 | -12.90% |
| Mar 31, 2022 | 28.95% |
| Dec 31, 2021 | -1.69% |
| Sep 30, 2021 | 66.80% |
| Jun 30, 2021 | 32.88% |